Amanda Leite Bastos-Pereira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Amanda Leite Bastos-Pereira has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Aderbal Silva Aguiar
Federal University of Santa Catarina
5 shared publications - Tatyana Nery
UFSC-Federal University of Santa Catarina
5 shared publications - Naiara de Souza Santos
Federal University of Santa Catarina
4 shared publications - Izabel Feltrin Fabro
Federal University of Santa Catarina
3 shared publications - Ana Cristina de Bem Alves
Universidade Federal de Santa Catarina
2 shared publications - Ana Paula Pinto de AraújO
UFSC-Federal University of Santa Catarina
2 shared publications
Latest Publications
- Open Access
- 30 September 2026
- Published by American Chemical Society (ACS) in ACS Pharmacology & Translational Science
- Vol. 9 (10) , 2772-2782
Cannabigerol Enhances Muscle Strength and Performance in Dexamethasone-Treated Mice
Sarcopenia is a major clinical condition associated with aging and is characterized by progressive loss of skeletal muscle mass and function. Resistance training is an effective intervention to counteract muscle atrophy; however, strategies that selectively enhance functional performance remain limited. Cannabigerol, a phytocannabinoid that is not a CB1 receptor agonist and therefore lacks psychotomimetic activity, has emerged as a potential modulator of neuromuscular function, although its role in skeletal muscle adaptation remains poorly understood. Here, we investigated the effects of resistance exercise and cannabigerol, alone and in combination, in a dexamethasone-induced model of muscle atrophy in mice. Animals received dexamethasone (20 mg/kg, i.p.) for 12 days and were subsequently subjected to a 4-week ladder-based resistance exercise protocol. Cannabigerol (10 mg/kg, i.p.) was administered on training days. Resistance exercise restored muscle morphology and improved fatigue resistance. In contrast, cannabigerol acted mainly on neuromuscular performance, increasing muscle power while producing only a small increase in fiber cross-sectional area. Cannabigerol potentiated training-induced power output, increasing performance by ∼55% in the first week and up to ∼87% after 4 weeks compared to exercise alone. In addition, cannabigerol increased peak grip strength (∼10%) and lowered post-exercise blood lactate in sedentary animals (∼48%). These findings show that resistance exercise and cannabigerol exert complementary effects on skeletal muscle─exercise promoting structural recovery and cannabigerol enhancing neuromuscular performance and lowering post-exercise lactate─and support further investigation of cannabigerol as an adjunct to exercise in glucocorticoid-induced muscle atrophy.
- 30 September 2026
- Published by American Chemical Society (ACS) in ACS Pharmacology & Translational Science
- Vol. 9 (10) , 2772-2782
Open AccessCannabigerol Enhances Muscle Strength and Performance in Dexamethasone-Treated Mice
Sarcopenia is a major clinical condition associated with aging and is characterized by progressive loss of skeletal muscle mass and function. Resistance training is an effective intervention to counteract muscle atrophy; however, strategies that selectively enhance functional performance remain limited. Cannabigerol, a phytocannabinoid that is not a CB1 receptor agonist and therefore lacks psychotomimetic activity, has emerged as a potential modulator of neuromuscular function, although its role in skeletal muscle adaptation remains poorly understood. Here, we investigated the effects of resistance exercise and cannabigerol, alone and in combination, in a dexamethasone-induced model of muscle atrophy in mice. Animals received dexamethasone (20 mg/kg, i.p.) for 12 days and were subsequently subjected to a 4-week ladder-based resistance exercise protocol. Cannabigerol (10 mg/kg, i.p.) was administered on training days. Resistance exercise restored muscle morphology and improved fatigue resistance. In contrast, cannabigerol acted mainly on neuromuscular performance, increasing muscle power while producing only a small increase in fiber cross-sectional area. Cannabigerol potentiated training-induced power output, increasing performance by ∼55% in the first week and up to ∼87% after 4 weeks compared to exercise alone. In addition, cannabigerol increased peak grip strength (∼10%) and lowered post-exercise blood lactate in sedentary animals (∼48%). These findings show that resistance exercise and cannabigerol exert complementary effects on skeletal muscle─exercise promoting structural recovery and cannabigerol enhancing neuromuscular performance and lowering post-exercise lactate─and support further investigation of cannabigerol as an adjunct to exercise in glucocorticoid-induced muscle atrophy.
- Open Access
- 29 September 2026
- Published by American Chemical Society (ACS) in ACS Pharmacology & Translational Science
- Vol. 9 (10) , 2783-2794
Central Blockade of Cannabinoid CB1 and CB2 Receptors Increases Force Generation in Reserpine-Treated Mice, but Only CB1 Blockade Extends the Duration of Effort
Motor impairment in parkinsonism extends beyond the classical triad to weakness and a reduced capacity to sustain motor output, whose neuromodulatory control is poorly resolved. The endocannabinoid system is a candidate regulator, but CB1 and CB2 receptors have not been separated within one preparation. Reserpine-treated adult female Swiss mice received vehicle, the CB1 antagonist AM251, or the CB2 antagonist AM630 into the lateral ventricle; catalepsy was recorded across three trials and neuromuscular performance in a grip force task. Both antagonists increased the force generated at task onset, by amounts these data cannot distinguish: AM630 by 53.9 gf (95% CI 22.5–85.3) and AM251 by 41.2 gf (95% CI 8.8–73.6). They separated on duration. AM251 increased grip time by 619 ms (95% CI 113–1125), whereas AM630 did not (−70 ms, 95% CI −560 to +421). An interaction contrast on the force–time balance followed from that difference: AM630 shifted the balance toward force (−2.03 SD, P = 0.008), AM251 did not (−0.36 SD, P = 0.66), and the two differed from each other by 1.67 SD (P = 0.022). AM251 also reduced the odds of a cataleptic response (OR 0.16, 95% CI 0.03–0.89). Adjusting for body mass left both force effects unchanged. The dissociation is therefore in the duration of effort rather than in its force: both antagonists raise force, and only CB1 blockade also extends the time over which it is maintained. Delivered intracerebroventricularly, these effects are central in origin but not anatomically localized.
- 29 September 2026
- Published by American Chemical Society (ACS) in ACS Pharmacology & Translational Science
- Vol. 9 (10) , 2783-2794
Open AccessCentral Blockade of Cannabinoid CB1 and CB2 Receptors Increases Force Generation in Reserpine-Treated Mice, but Only CB1 Blockade Extends the Duration of Effort
Motor impairment in parkinsonism extends beyond the classical triad to weakness and a reduced capacity to sustain motor output, whose neuromodulatory control is poorly resolved. The endocannabinoid system is a candidate regulator, but CB1 and CB2 receptors have not been separated within one preparation. Reserpine-treated adult female Swiss mice received vehicle, the CB1 antagonist AM251, or the CB2 antagonist AM630 into the lateral ventricle; catalepsy was recorded across three trials and neuromuscular performance in a grip force task. Both antagonists increased the force generated at task onset, by amounts these data cannot distinguish: AM630 by 53.9 gf (95% CI 22.5–85.3) and AM251 by 41.2 gf (95% CI 8.8–73.6). They separated on duration. AM251 increased grip time by 619 ms (95% CI 113–1125), whereas AM630 did not (−70 ms, 95% CI −560 to +421). An interaction contrast on the force–time balance followed from that difference: AM630 shifted the balance toward force (−2.03 SD, P = 0.008), AM251 did not (−0.36 SD, P = 0.66), and the two differed from each other by 1.67 SD (P = 0.022). AM251 also reduced the odds of a cataleptic response (OR 0.16, 95% CI 0.03–0.89). Adjusting for body mass left both force effects unchanged. The dissociation is therefore in the duration of effort rather than in its force: both antagonists raise force, and only CB1 blockade also extends the time over which it is maintained. Delivered intracerebroventricularly, these effects are central in origin but not anatomically localized.
- Open Access
- 8 September 2026
- Published by American Chemical Society (ACS) in ACS Pharmacology & Translational Science
- Vol. 9 (10) , 2950-2959
Purinergic P2X7 Receptor Antagonism Impairs Aerobic Capacity without Detectable Effect on Cardiac Adaptation to Exercise in Mice
Adenosine triphosphate (ATP) signaling through the P2X7 receptor is an emerging determinant of mitochondrial energy metabolism and physical fitness, and the receptor is increasingly targeted pharmacologically for its role in inflammation. Whether systemic P2X7 antagonism affects aerobic capacity and the structural adaptation of the heart to exercise is unknown. Adult male Swiss mice were studied in a 2 × 2 factorial design crossing physical conditioning (sedentary or exercised) with treatment (saline or the P2X7 antagonist Brilliant Blue G, BBG; 50 mg/kg). Exercised animals trained on a treadmill on alternate days over approximately 4 weeks; maximal oxygen uptake (V̇O2max) and power were measured by incremental treadmill ergospirometry, and myocardial cardiomyocyte volume density (Vv) was quantified by design-based stereology. Aerobic training increased V̇O2max and cardiomyocyte Vv. BBG reduced V̇O2max and peak power independently of training and produced a deficit that widened progressively with workload across the incremental test, indicating a demand-dependent limitation of oxidative performance. Critically, BBG did not detectably alter the exercise-induced increase in cardiomyocyte Vv and showed no interaction with training; motor coordination, locomotor and exploratory behavior, blood lactate, and body mass were also unaffected. P2X7 antagonism thus impairs aerobic capacity without detectable blunting of the structural response of the heart to exercise. This functional–structural dissociation points to a metabolic process, plausibly mitochondrial, rather than to cardiac remodeling, although the present sample size bounds rather than excludes an effect on cardiac adaptation, and indicates that P2X7-directed therapies may reduce exercise capacity without producing overt cardiac structural change.
- 8 September 2026
- Published by American Chemical Society (ACS) in ACS Pharmacology & Translational Science
- Vol. 9 (10) , 2950-2959
Open AccessPurinergic P2X7 Receptor Antagonism Impairs Aerobic Capacity without Detectable Effect on Cardiac Adaptation to Exercise in Mice
Adenosine triphosphate (ATP) signaling through the P2X7 receptor is an emerging determinant of mitochondrial energy metabolism and physical fitness, and the receptor is increasingly targeted pharmacologically for its role in inflammation. Whether systemic P2X7 antagonism affects aerobic capacity and the structural adaptation of the heart to exercise is unknown. Adult male Swiss mice were studied in a 2 × 2 factorial design crossing physical conditioning (sedentary or exercised) with treatment (saline or the P2X7 antagonist Brilliant Blue G, BBG; 50 mg/kg). Exercised animals trained on a treadmill on alternate days over approximately 4 weeks; maximal oxygen uptake (V̇O2max) and power were measured by incremental treadmill ergospirometry, and myocardial cardiomyocyte volume density (Vv) was quantified by design-based stereology. Aerobic training increased V̇O2max and cardiomyocyte Vv. BBG reduced V̇O2max and peak power independently of training and produced a deficit that widened progressively with workload across the incremental test, indicating a demand-dependent limitation of oxidative performance. Critically, BBG did not detectably alter the exercise-induced increase in cardiomyocyte Vv and showed no interaction with training; motor coordination, locomotor and exploratory behavior, blood lactate, and body mass were also unaffected. P2X7 antagonism thus impairs aerobic capacity without detectable blunting of the structural response of the heart to exercise. This functional–structural dissociation points to a metabolic process, plausibly mitochondrial, rather than to cardiac remodeling, although the present sample size bounds rather than excludes an effect on cardiac adaptation, and indicates that P2X7-directed therapies may reduce exercise capacity without producing overt cardiac structural change.
- Open Access
- 31 August 2026
- Published by American Chemical Society (ACS) in ACS Pharmacology & Translational Science
- Vol. 9 (9) , 2617-2627
Acute Submaximal Running Potentiates the Straub Tail Response to Meperidine in a Dose- and Sex-Dependent Manner in Mice
Physical exercise recruits endogenous opioid mechanisms in the central nervous system, but whether this physiological opioid tone potentiates the effects of exogenous μ-agonists, and whether such interactions differ between sexes, remains unknown. Here, we used the Straub tail response as a behavioral index of central μ2-opioid receptor activity to investigate whether acute submaximal running modulates the pharmacodynamic effects of meperidine in male and female Swiss mice. In resting animals, meperidine produced a dose- and time-dependent Straub tail response across a 12-fold dose range, and the submaximal doses of 8 and 12 mg/kg were selected for treadmill experiments. Running at approximately 70% of V̇O2 max potentiated the Straub tail response at 12 mg/kg in both sexes, with the effect substantially larger in females, as indicated by a significant Sex × Exercise interaction. Thermal antinociception was equivalent between sexes at 12 mg/kg, indicating that the dimorphism was specific to the exercise-opioid interaction rather than to baseline drug sensitivity. A separate experiment testing whether running alone elicits a naloxone-sensitive response was inconclusive in both sexes; under opioid receptor blockade, however, females maintained higher running-induced scores than males, indicating that the sex difference persists during naloxone treatment. These findings indicate that acute submaximal running potentiates the Straub tail response to meperidine in a dose- and sex-dependent manner. The sexually dimorphic nature of this interaction suggests that biological sex and exercise intensity may jointly modulate opioid pharmacodynamics during physical activity.
- 31 August 2026
- Published by American Chemical Society (ACS) in ACS Pharmacology & Translational Science
- Vol. 9 (9) , 2617-2627
Open AccessAcute Submaximal Running Potentiates the Straub Tail Response to Meperidine in a Dose- and Sex-Dependent Manner in Mice
Physical exercise recruits endogenous opioid mechanisms in the central nervous system, but whether this physiological opioid tone potentiates the effects of exogenous μ-agonists, and whether such interactions differ between sexes, remains unknown. Here, we used the Straub tail response as a behavioral index of central μ2-opioid receptor activity to investigate whether acute submaximal running modulates the pharmacodynamic effects of meperidine in male and female Swiss mice. In resting animals, meperidine produced a dose- and time-dependent Straub tail response across a 12-fold dose range, and the submaximal doses of 8 and 12 mg/kg were selected for treadmill experiments. Running at approximately 70% of V̇O2 max potentiated the Straub tail response at 12 mg/kg in both sexes, with the effect substantially larger in females, as indicated by a significant Sex × Exercise interaction. Thermal antinociception was equivalent between sexes at 12 mg/kg, indicating that the dimorphism was specific to the exercise-opioid interaction rather than to baseline drug sensitivity. A separate experiment testing whether running alone elicits a naloxone-sensitive response was inconclusive in both sexes; under opioid receptor blockade, however, females maintained higher running-induced scores than males, indicating that the sex difference persists during naloxone treatment. These findings indicate that acute submaximal running potentiates the Straub tail response to meperidine in a dose- and sex-dependent manner. The sexually dimorphic nature of this interaction suggests that biological sex and exercise intensity may jointly modulate opioid pharmacodynamics during physical activity.
- Open Access
- 8 April 2026
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 138 (5) , e70230
In Vitro Antitrypanosomal and Antibacterial Activity of Aqueous, Hydroethanolic and Ethanolic Extracts of Rumex obtusifolius L. Leaf and Root
Plant extracts are an important raw material for the development of new drugs. Rumex obtusifolius L., popularly known as ‘bitter dock’, has significant pharmacological properties. This study evaluated the in vitro antitrypanosomal activity of aqueous, hydroethanolic and ethanolic extracts from the leaf and roots of R. obtusifolius L. against Trypanosoma evansi , as well as their antibacterial activity against Escherichia coli and Streptococcus aureus . Antitrypanosomal assays were performed using extract concentrations of 0.5%, 1% and 2% and analysed by flow cytometry (necrosis). The antimicrobial activity was assessed at 1–100 mg/mL. Cytotoxicity was evaluated in mammalian cells for extracts active against T. evansi . The hydroethanolic and ethanolic leaf extracts exhibited significant anti‐ T. evansi activity, inducing necrosis rates of 64.6% and 63.7%, respectively. Besides, treatment with the ethanolic leaf extract (2%) of R. obtusifolius reduced cell viability to 14.3% after 24 h, whereas the hydroethanolic extract (2%) exhibited lower cytotoxicity, with cell viability remaining at approximately 65%–70%. None of the extracts exhibited antibacterial activity. In addition, our findings demonstrate a previously unreported pharmacological property of R. obtusifolius : the antitrypanosomal activity of its hydroethanolic and ethanolic extracts against T. evansi . Nevertheless, further studies are required to elucidate the mechanisms of action and to confirm a possible in vivo antitrypanosomal efficacy of these extracts.
- 8 April 2026
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 138 (5) , e70230
Open AccessIn Vitro Antitrypanosomal and Antibacterial Activity of Aqueous, Hydroethanolic and Ethanolic Extracts of Rumex obtusifolius L. Leaf and Root
Plant extracts are an important raw material for the development of new drugs. Rumex obtusifolius L., popularly known as ‘bitter dock’, has significant pharmacological properties. This study evaluated the in vitro antitrypanosomal activity of aqueous, hydroethanolic and ethanolic extracts from the leaf and roots of R. obtusifolius L. against Trypanosoma evansi , as well as their antibacterial activity against Escherichia coli and Streptococcus aureus . Antitrypanosomal assays were performed using extract concentrations of 0.5%, 1% and 2% and analysed by flow cytometry (necrosis). The antimicrobial activity was assessed at 1–100 mg/mL. Cytotoxicity was evaluated in mammalian cells for extracts active against T. evansi . The hydroethanolic and ethanolic leaf extracts exhibited significant anti‐ T. evansi activity, inducing necrosis rates of 64.6% and 63.7%, respectively. Besides, treatment with the ethanolic leaf extract (2%) of R. obtusifolius reduced cell viability to 14.3% after 24 h, whereas the hydroethanolic extract (2%) exhibited lower cytotoxicity, with cell viability remaining at approximately 65%–70%. None of the extracts exhibited antibacterial activity. In addition, our findings demonstrate a previously unreported pharmacological property of R. obtusifolius : the antitrypanosomal activity of its hydroethanolic and ethanolic extracts against T. evansi . Nevertheless, further studies are required to elucidate the mechanisms of action and to confirm a possible in vivo antitrypanosomal efficacy of these extracts.
- Open Access
- 18 November 2025
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 10 (47) , 57568-57577
Prior Exercise Attenuates LPS-Induced Neuroinflammation, Dopaminergic Dysfunction, and Fatigue-like Behavior in Mice
Purpose: Neuroinflammation contributes to central fatigue by disrupting dopaminergic signaling and motivational circuits. This study investigated whether prior voluntary exercise attenuates behavioral, physiological, and neurochemical alterations induced by systemic inflammation. Methods: Adult male Swiss mice (8–10 weeks old, 35–40 g) were assigned to sedentary or runner groups. with 6 weeks of free wheel running. Systemic inflammation was induced via intraperitoneal injections of lipopolysaccharide (LPS, 0.33 mg/kg, Escherichia coli), while controls received saline (0.9% NaCl). Behavioral assessments included locomotion, grooming, and social interaction. Fatigue-related outcomes were evaluated via maximal oxygen consumption (V̇O2max) and grip strength. Prefrontal cortex IL-1β and IL-6 levels were quantified by ELISA, and dopaminergic metabolism was assessed by HPLC. Results: LPS exposure elicited marked neuroinflammatory responseselevated IL-1β and IL-6and disrupted dopamine metabolism in the prefrontal cortex. These changes correlated with impaired behavior, reduced V̇O2max, and diminished grip strength. Prior exercise attenuated IL-6 elevation, preserved dopaminergic markers, and mitigated some behavioral and functional deficits. However, IL-1β levels remained elevated and protection was incomplete. Conclusion: Systemic inflammation is associated with impaired CNS function, reflected by neuroinflammatory changes and alterations in dopaminergic metabolism. Prior physical activity confers partial protection, reducing IL-6 and preserving behavioral and metabolic performance. These findings highlight the potential of exercise as a preventive strategy against inflammation-induced central fatigue.
- 18 November 2025
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 10 (47) , 57568-57577
Open AccessPrior Exercise Attenuates LPS-Induced Neuroinflammation, Dopaminergic Dysfunction, and Fatigue-like Behavior in Mice
Purpose: Neuroinflammation contributes to central fatigue by disrupting dopaminergic signaling and motivational circuits. This study investigated whether prior voluntary exercise attenuates behavioral, physiological, and neurochemical alterations induced by systemic inflammation. Methods: Adult male Swiss mice (8–10 weeks old, 35–40 g) were assigned to sedentary or runner groups. with 6 weeks of free wheel running. Systemic inflammation was induced via intraperitoneal injections of lipopolysaccharide (LPS, 0.33 mg/kg, Escherichia coli), while controls received saline (0.9% NaCl). Behavioral assessments included locomotion, grooming, and social interaction. Fatigue-related outcomes were evaluated via maximal oxygen consumption (V̇O2max) and grip strength. Prefrontal cortex IL-1β and IL-6 levels were quantified by ELISA, and dopaminergic metabolism was assessed by HPLC. Results: LPS exposure elicited marked neuroinflammatory responseselevated IL-1β and IL-6and disrupted dopamine metabolism in the prefrontal cortex. These changes correlated with impaired behavior, reduced V̇O2max, and diminished grip strength. Prior exercise attenuated IL-6 elevation, preserved dopaminergic markers, and mitigated some behavioral and functional deficits. However, IL-1β levels remained elevated and protection was incomplete. Conclusion: Systemic inflammation is associated with impaired CNS function, reflected by neuroinflammatory changes and alterations in dopaminergic metabolism. Prior physical activity confers partial protection, reducing IL-6 and preserving behavioral and metabolic performance. These findings highlight the potential of exercise as a preventive strategy against inflammation-induced central fatigue.
- 19 July 2024
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 209
Electronic von Frey associated with the Mouse Grimace Scale to Assess Allodynia and Pain in Trypanosoma evansi-Infected Mice
Infectious disease pathogenesis is still a complex field to study. The course of several clinical signs, such as allodynia and pain, may be observed in ... Jove
- 19 July 2024
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 209
Electronic von Frey associated with the Mouse Grimace Scale to Assess Allodynia and Pain in Trypanosoma evansi-Infected Mice
Infectious disease pathogenesis is still a complex field to study. The course of several clinical signs, such as allodynia and pain, may be observed in ... Jove
- 28 January 2023
- Published by Elsevier in Experimental Parasitology
- Vol. 247, 108477
Experimental Trypanosoma evansi infection induces pain along with oxidative stress, prevented by COX-2 inhibition
- 28 January 2023
- Published by Elsevier in Experimental Parasitology
- Vol. 247, 108477
Experimental Trypanosoma evansi infection induces pain along with oxidative stress, prevented by COX-2 inhibition
- Open Access
- 1 January 2022
- Published by Universidade Federal do Rio Grande do Sul in Acta Scientiae Veterinariae
- Vol. 50
Nasal Transmissible Venereal Tumor (TVT) in Dogs
Background: Transmissible venereal tumors (TVT) are naturally occurring neoplasms that can be transmitted through copulation or cell transplantation. It is a disease that affects canines, has no preference for sex or breed, and generally noticed in the external genital apparatus. Extragenital occurrence may eventually be seen; however, nasal involvement has been described in only a few reports of studies conducted in Brazil. Therefore, the objective of this study is to report 3 cases of nasal TVT in dogs who were treated in 2 municipalities in the mountainous region of Santa Catarina, Brazil.Cases: This case report includes 3 male mixed-breed canines of age 3-13. Only 1 of the animals was castrated. As per the medical history, some points, such as an enlarged nasal region, sneezing, nasal discharge, and hoarseness, reported by the dogs’ respective owners were similar among all the dogs. Likewise, nosebleed was observed on physical examination in all the cases. The result of cytological examination was inconclusive only in 1 case. Rhinoscopy, incisional biopsy, and histopathological examination were then performed for achieving a definitive diagnosis. In the 2 cases wherein cytology gave conclusive results, the cytological smears showed changes suggestive of TVT, such as cells with eccentric nuclei and little cytoplasm, which had vacuoles inside them. In 2 cases, radiographic examinations of the skull were also performed. The images showed changes in bone radiopacity, conformation of trabeculae with areas of bone lysis and cell proliferation, and irregularity in the contour of the nasal bone. After TVT diagnosis was confirmed, chemotherapy was initiated using vincristine at a dose of 0.75 mg/m2 for 2 cases and 0.025 mg/kg for the remaining case. The number of chemotherapy sessions and duration of treatment until the resolution of lesions and clinical signs varied as per the differences in the patients’ blood counts performed prior to each session.Discussion: TVT occurs between 1 and 7 years of life. It occurs more frequently in sexually active animals and has no preference for breed. Of the 3 cases reported herein, only one of the patients was elderly. All the patients were male mixed-breed dogs, and only 1 of them was castrated. The implantation of neoplastic cells through natural mounts, licks, scratches, or bites of affected areas are the most widely accepted reasons for the transmission of this neoplasm. With regard to the nasal presentation described in the present report, it is hypothesized that the smelling or licking of the neoplastic areas by the animal may favor cell implantation, leading to the subsequent development of a tumor. Nasal TVT should be considered as a differential diagnosis for dogs with chronic symptoms of the upper respiratory tract, such as increased local volume, nasal discharge, nosebleed, and sneezing. These signs are consistent with those described in this report. Radiographic evaluation was performed in 2 cases and both showed changes in bone radiopacity and trabeculae conformation, in addition to areas of bone lysis and cell proliferation, which are common in neoplastic processes. A presumptive diagnosis can be achieved from the medical history, clinical signs, and physical examination. Cytological and histopathological examination are the confirmatory methods; however, it is used less frequently and especially when cytological evaluation does not provide a definitive diagnosis. Antineoplastic chemotherapy with vincristine is the first-choice treatment protocol, which also proved to be effective for the patients in this report. Although TVT commonly affects the external genitalia of dogs, in the cases reported herein, it was located exclusively in the nasal region. Keywords: TVT, dog, nasal, vincristine.Título: Tumor venéreo transmissível (TVT) nasal em cãesDescritores: TVT, cão, nasal, vincristine.
- 1 January 2022
- Published by Universidade Federal do Rio Grande do Sul in Acta Scientiae Veterinariae
- Vol. 50
Open AccessNasal Transmissible Venereal Tumor (TVT) in Dogs
Background: Transmissible venereal tumors (TVT) are naturally occurring neoplasms that can be transmitted through copulation or cell transplantation. It is a disease that affects canines, has no preference for sex or breed, and generally noticed in the external genital apparatus. Extragenital occurrence may eventually be seen; however, nasal involvement has been described in only a few reports of studies conducted in Brazil. Therefore, the objective of this study is to report 3 cases of nasal TVT in dogs who were treated in 2 municipalities in the mountainous region of Santa Catarina, Brazil.Cases: This case report includes 3 male mixed-breed canines of age 3-13. Only 1 of the animals was castrated. As per the medical history, some points, such as an enlarged nasal region, sneezing, nasal discharge, and hoarseness, reported by the dogs’ respective owners were similar among all the dogs. Likewise, nosebleed was observed on physical examination in all the cases. The result of cytological examination was inconclusive only in 1 case. Rhinoscopy, incisional biopsy, and histopathological examination were then performed for achieving a definitive diagnosis. In the 2 cases wherein cytology gave conclusive results, the cytological smears showed changes suggestive of TVT, such as cells with eccentric nuclei and little cytoplasm, which had vacuoles inside them. In 2 cases, radiographic examinations of the skull were also performed. The images showed changes in bone radiopacity, conformation of trabeculae with areas of bone lysis and cell proliferation, and irregularity in the contour of the nasal bone. After TVT diagnosis was confirmed, chemotherapy was initiated using vincristine at a dose of 0.75 mg/m2 for 2 cases and 0.025 mg/kg for the remaining case. The number of chemotherapy sessions and duration of treatment until the resolution of lesions and clinical signs varied as per the differences in the patients’ blood counts performed prior to each session.Discussion: TVT occurs between 1 and 7 years of life. It occurs more frequently in sexually active animals and has no preference for breed. Of the 3 cases reported herein, only one of the patients was elderly. All the patients were male mixed-breed dogs, and only 1 of them was castrated. The implantation of neoplastic cells through natural mounts, licks, scratches, or bites of affected areas are the most widely accepted reasons for the transmission of this neoplasm. With regard to the nasal presentation described in the present report, it is hypothesized that the smelling or licking of the neoplastic areas by the animal may favor cell implantation, leading to the subsequent development of a tumor. Nasal TVT should be considered as a differential diagnosis for dogs with chronic symptoms of the upper respiratory tract, such as increased local volume, nasal discharge, nosebleed, and sneezing. These signs are consistent with those described in this report. Radiographic evaluation was performed in 2 cases and both showed changes in bone radiopacity and trabeculae conformation, in addition to areas of bone lysis and cell proliferation, which are common in neoplastic processes. A presumptive diagnosis can be achieved from the medical history, clinical signs, and physical examination. Cytological and histopathological examination are the confirmatory methods; however, it is used less frequently and especially when cytological evaluation does not provide a definitive diagnosis. Antineoplastic chemotherapy with vincristine is the first-choice treatment protocol, which also proved to be effective for the patients in this report. Although TVT commonly affects the external genitalia of dogs, in the cases reported herein, it was located exclusively in the nasal region. Keywords: TVT, dog, nasal, vincristine.Título: Tumor venéreo transmissível (TVT) nasal em cãesDescritores: TVT, cão, nasal, vincristine.